COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹646 Cr | ₹705 Cr | ₹117 Cr | ₹303 Cr | ₹348 Cr |
What is the latest Total Current Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹646 Cr |
| Mar2025 | ₹705 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹348 Cr |
How is Total Current Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹646 Cr | -8.43 | |
| Mar2025 | ₹705 Cr | 500.86 | |
| Mar2024 | ₹117 Cr | -61.27 | |
| Mar2023 | ₹303 Cr | -12.79 | |
| Mar2022 | ₹348 Cr | - | |
Compare Total Current Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,366.2 Cr | 0.3% | -0% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 0.3% |
-0% |
-49.1% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses